ARTICLE
2 April 2025

CD Milan, March 27, 2025, Procedural Order On Application To Intervene, UPC_CFI_698/2024

BP
Bardehle Pagenberg

Contributor

BARDEHLE PAGENBERG combines the expertise of attorneys-at-law and patent attorneys. As one of the largest IP firms in Europe, BARDEHLE PAGENBERG advises in all fields of Intellectual Property, including all procedures before the patent and trademark offices as well as litigation before the courts through all instances.
The intervener must demonstrate a direct and present legal interest in the specific outcome sought by the supported party, a mere "guiding effect" on future cases does not establish...
Italy Intellectual Property

1. Key takeaways

Parallelism between two cases or the allegation that the outcome of a judgment has a direct impact on another does not establish a legal interest to intervention pursuant to RoP 313.

The intervener must demonstrate a direct and present legal interest in the specific outcome sought by the supported party, a mere "guiding effect" on future cases does not establish a sufficient legal interest for an intervention.

2. Division

Central Division Milan

3. UPC number

UPC_CFI_698/2024

4. Type of proceedings

Place type of proceedings

5. Parties

Claimant: Accord Healthcare Group ("ACCORD")

Defendant: Novartis AG ("Novartis")

Applicants for Intervention: Zentiva k.s. and Zentiva Portugal, LDA ("Zentiva")

6. Patent(s)

EP 3 501 384

7. Body of legislation / Rules

Rule 313 RoP, Article 33 UPCA

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More